KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

QuidelOrtho (QDEL) Raw Materials (2022 - 2025)

QuidelOrtho's Raw Materials history spans 4 years, with the latest figure at $189.9 million for Q4 2025.

  • On a quarterly basis, Raw Materials fell 10.34% to $189.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $189.9 million, a 10.34% decrease, with the full-year FY2025 number at $189.9 million, down 10.34% from a year prior.
  • Raw Materials hit $189.9 million in Q4 2025 for QuidelOrtho, down from $193.1 million in the prior quarter.
  • Over the last five years, Raw Materials for QDEL hit a ceiling of $222.3 million in Q2 2024 and a floor of $103.2 million in Q1 2022.
  • Historically, Raw Materials has averaged $199.0 million across 4 years, with a median of $204.4 million in 2023.
  • Biggest five-year swings in Raw Materials: soared 79.46% in 2023 and later fell 10.34% in 2025.
  • Tracing QDEL's Raw Materials over 4 years: stood at $189.5 million in 2022, then rose by 12.24% to $212.7 million in 2023, then fell by 0.42% to $211.8 million in 2024, then fell by 10.34% to $189.9 million in 2025.
  • Business Quant data shows Raw Materials for QDEL at $189.9 million in Q4 2025, $193.1 million in Q3 2025, and $205.6 million in Q2 2025.